BioAtla (BCAB)
(Delayed Data from NSDQ)
$1.73 USD
-0.03 (-1.70%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $1.81 +0.08 (4.62%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.34 |
EPS Last Quarter | -0.44 |
Last EPS Surprise | 2.22% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.52 |
Next Year | -1.74 |
EPS (TTM) | -2.18 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.34 | -0.35 | -1.52 | -1.74 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.34 | -0.35 | -1.52 | -1.74 |
Low Estimate | -0.34 | -0.35 | -1.52 | -1.74 |
Year ago EPS | -0.70 | -0.56 | -2.58 | -1.52 |
Year over Year Growth Est. | 51.43% | 37.50% | 41.09% | -14.47% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.34 | -0.35 | -1.52 | -1.74 |
7 Days Ago | -0.34 | -0.35 | -1.52 | -1.74 |
30 Days Ago | -0.28 | -0.29 | -1.37 | -1.21 |
60 Days Ago | -0.34 | -0.32 | -1.51 | -1.39 |
90 Days Ago | -0.34 | -0.32 | -1.51 | -1.39 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.34 | -0.35 | -1.52 | -1.74 |
Zacks Consensus Estimate | -0.34 | -0.35 | -1.52 | -1.74 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.44 | -0.48 | -0.56 | -0.70 | NA |
Estimate | -0.45 | -0.57 | -0.68 | -0.77 | NA |
Difference | 0.01 | 0.09 | 0.12 | 0.07 | 0.07 |
Surprise | 2.22% | 15.79% | 17.65% | 9.09% | 11.19% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more